Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Cancers
|
October 27, 2018
Druggable <i>Nucleolin</i> Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
Flora Nguyen Van Long, Audrey Lardy-Cleaud, Susan Bray, et al.
Scottish Medical Journal
|
December 28, 2022
Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality
Thineskrishna Anbarasan, Sheikh Nissar, Julie Turbitt, et al.
Oncotarget
|
March 28, 2018
Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma
Aidan M Rose, Lindsay C Spender, Christopher Stephen, et al.
BMC Cancer
|
May 11, 2022
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer
Flora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carène, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Cancers
|
October 27, 2018
Druggable <i>Nucleolin</i> Identifies Breast Tumours Associated with Poor Prognosis That Exhibit Different Biological Processes
Flora Nguyen Van Long, Audrey Lardy-Cleaud, Susan Bray, et al.
Scottish Medical Journal
|
December 28, 2022
Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality
Thineskrishna Anbarasan, Sheikh Nissar, Julie Turbitt, et al.
Oncotarget
|
March 28, 2018
Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma
Aidan M Rose, Lindsay C Spender, Christopher Stephen, et al.
BMC Cancer
|
May 11, 2022
Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer
Flora Nguyen Van Long, Audrey Lardy-Cleaud, Dimitri Carène, et al.
Page
of 2